Amira I. Aldesoky

Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy

Due to a lack of efficient screening methods or trustworthy biomarkers with high sensitivity and specificity, ovarian cancer (OC) is a quarrelsome disease with a high death rate. Investigators believe that circulating tumor cell-free DNA (cfDNA) can provide crucial clues concerni...